Literature DB >> 34087686

Coping with stress during the first wave of the COVID-19 pandemic by Turkish people with Multiple Sclerosis: The relationship between perceived stress and quality of life.

Bengu Altunan1, Aysun Unal2, Ayhan Bingöl3, Filiz Dilek4, Derya Girgin5.   

Abstract

BACKGROUND: Multiple sclerosis (MS) is a chronic inflammatory disease and acute exacerbations are also a part of the clinical course. The presence of the disease and relapses cause stress in people with MS (pwMS). For this reason, stress coping strategies of the patients are important in reducing perceived stress. Our aim in this study is to evaluate which strategies pwMS use during the COVID-19 pandemic, the effect of the strategies on perceived stress, their relationship with relapses and their role on quality of life (QoL).
METHODS: An online form including Perceived Stress Scale (PSS; 10 items), Coping with Experienced Problems Scale (Brief-COPE; 28 items) and SF-12 were sent to 340 pwMS under our follow-up.
RESULTS: During the COVID-19 pandemic, we found that the patients used the strategies of turn to religion, planning and acceptance at a high rate. PSS score was high in 23 (11.2%) of the patients. The patients with low perceived stress used the acceptance strategy more (P=0.008). We found a negative correlation between physical component summary (PCS) of SF-12 and denial (r=-0.2, p<0.001) and distraction (r =-0.1, p=0.04). A negative correlation was found between mental component summary (MCS) of SF-12 and behavioral disconnection (r=-0.2, p=0.006). There was a positive correlation between MCS and humor (r=0.1, p=0.04), use of instrumental support (r=0.2, p=0.009), planning (r=0.1, p=0.04), and positive reframing (r=0.2, p=0.002).
CONCLUSION: PwMS have been successful in coping with stress in the first half of the pandemic with the combination of emotional and problem-focused strategies. Acceptance strategy was highly adopted by patients with low PSS, and the tendency to use the active coping strategy together with the acceptance strategy was high in patients without relapses. Adoption to emotional strategies may have prevented the severe deterioration in QoL in this study group in the early period of Covid-19 pandemic.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  COVID-19 pandemic; Coping strategies; Multiple sclerosis; Perceived stress; Quality of life; Relapse

Year:  2021        PMID: 34087686     DOI: 10.1016/j.msard.2021.103039

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  5 in total

1.  Higher Perceived Stress as an Independent Predictor for Lower Use of Emotion-Focused Coping Strategies in Hypertensive Individuals.

Authors:  Laura Aló Torres; Regina Silva Paradela; Luiza Menoni Martino; Danielle Irigoyen da Costa; Maria Claudia Irigoyen
Journal:  Front Psychol       Date:  2022-05-24

2.  Depression, Anxiety, Stress, and Their Associations With Quality of Life in a Nationwide Sample of Psychiatrists in China During the COVID-19 Pandemic.

Authors:  Mengdie Li; Lei Xia; Yating Yang; Ling Zhang; Shujing Zhang; Tingfang Liu; Yuanli Liu; Nadine J Kaslow; Feng Jiang; Yi-Lang Tang; Huanzhong Liu
Journal:  Front Psychol       Date:  2022-06-23

3.  Criterion Validity and Reliability of SF-12 Health Survey Version 2 (SF-12v2) in a Student Population during COVID-19 Pandemic: A Cross-Sectional Study.

Authors:  Ilaria Ruotolo; Anna Berardi; Giovanni Sellitto; Francescaroberta Panuccio; Antonella Polimeni; Donatella Valente; Giovanni Galeoto
Journal:  Depress Res Treat       Date:  2021-08-04

Review 4.  Psychological impacts of COVID-19 pandemic on individuals living with multiple sclerosis: A rapid systematic review.

Authors:  Amin Zarghami; Mohammad A Hussain; Julie A Campbell; Chigozie Ezegbe; Ingrid van der Mei; Bruce V Taylor; Suzi B Claflin
Journal:  Mult Scler Relat Disord       Date:  2022-01-25       Impact factor: 4.808

5.  Mental Health Status of People with Multiple Sclerosis during the COVID-19 Pandemic.

Authors:  Maciej Wilski; Magdalena Koper; Jarosław Gabryelski; Waldemar Brola; Tomasz Tasiemski
Journal:  J Clin Med       Date:  2022-01-24       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.